pubmed-article:12616343 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0040300 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0085295 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0383327 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C1706515 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C2243049 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0165519 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C1704640 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C1706968 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0030685 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C1709059 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0680255 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0391871 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C1283071 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C1963578 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0392760 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C1548602 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
pubmed-article:12616343 | lifeskim:mentions | umls-concept:C0331858 | lld:lifeskim |
pubmed-article:12616343 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12616343 | pubmed:dateCreated | 2003-3-4 | lld:pubmed |
pubmed-article:12616343 | pubmed:abstractText | The proinflammatory cytokine interleukin (IL)-18 appears to be involved in the etiology of a variety of pathological conditions, among them rheumatoid arthritis and atherosclerosis as well as tumor growth and metastasis. As biological activity of matrix metalloproteinase-9 (MMP-9) has been identified as a hallmark in the pathogenesis of these diseases, effects of IL-18 on MMP-9 production by human peripheral blood mononuclear cells (PBMC) were investigated. Moreover, effects of immunopharmacological intervention by anti-tumor necrosis factor-alpha (TNFalpha) or IL-10 were evaluated. Here we report that IL-18 augmented production of MMP-9 by PBMC. The potency of IL-18 to induce release of MMP-9 from PBMC was comparable with that of TNFalpha. MMP-9 production was dependent on endogenous production of TNFalpha, as detected by use of neutralizing monoclonal antibodies. Whereas IL-18 and TNFalpha induced the protease, MMP-9 release was not mediated by IFNgamma. IL-18 also induced secretion of MMP-9 from human whole blood cultures. Antiinflammatory IL-10 efficiently downregulated release of MMP-9 from unstimulated and IL-18-activated PBMC. In contrast to MMP-9, secretion of tissue inhibitor of metalloproteinases-1 (TIMP-1) was not augmented by IL-18. Addition of IL-10 enhanced release of TIMP-1 from PBMC. The present study broadens the current pattern of IL-18 proinflammatory actions on PBMC, emphasizes the pivotal role of intermediate TNFalpha production in these responses, and relates IL-18 biological functions to the pathological role of MMP-9. | lld:pubmed |
pubmed-article:12616343 | pubmed:language | eng | lld:pubmed |
pubmed-article:12616343 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12616343 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12616343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12616343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12616343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12616343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12616343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12616343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12616343 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12616343 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12616343 | pubmed:month | Jan | lld:pubmed |
pubmed-article:12616343 | pubmed:issn | 0028-1298 | lld:pubmed |
pubmed-article:12616343 | pubmed:author | pubmed-author:EberhardtWolf... | lld:pubmed |
pubmed-article:12616343 | pubmed:author | pubmed-author:Pfeilschifter... | lld:pubmed |
pubmed-article:12616343 | pubmed:author | pubmed-author:NoldMarcelM | lld:pubmed |
pubmed-article:12616343 | pubmed:author | pubmed-author:MühlHeikoH | lld:pubmed |
pubmed-article:12616343 | pubmed:author | pubmed-author:GoedeAndreasA | lld:pubmed |
pubmed-article:12616343 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12616343 | pubmed:volume | 367 | lld:pubmed |
pubmed-article:12616343 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12616343 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12616343 | pubmed:pagination | 68-75 | lld:pubmed |
pubmed-article:12616343 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:meshHeading | pubmed-meshheading:12616343... | lld:pubmed |
pubmed-article:12616343 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12616343 | pubmed:articleTitle | IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10. | lld:pubmed |
pubmed-article:12616343 | pubmed:affiliation | Pharmazentrum Frankfurt, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. | lld:pubmed |
pubmed-article:12616343 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12616343 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:3586 | entrezgene:pubmed | pubmed-article:12616343 | lld:entrezgene |
entrez-gene:3606 | entrezgene:pubmed | pubmed-article:12616343 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12616343 | lld:pubmed |